| Literature DB >> 30759118 |
Michael Masaracchio1, Kaitlin Kirker1, Rebecca States1, William J Hanney2, Xinliang Liu3, Morey Kolber4.
Abstract
OBJECTIVE: To investigate the role of thoracic spine manipulation (TSM) on pain and disability in the management of mechanical neck pain (MNP). DATA SOURCES: Electronic databases PubMed, CINAHL, Pedro, Embase, AMED, the Cochrane Library, and clinicaltrials.gov were searched in January 2018. STUDY SELECTION: Eligible studies were completed RCTs, written in English, had at least 2 groups with one group receiving TSM, had at least one measure of pain or disability, and included patients with MNP of any duration. The search identified 1717 potential articles, with 14 studies meeting inclusion criteria. STUDY APPRAISAL AND SYNTHESISEntities:
Mesh:
Year: 2019 PMID: 30759118 PMCID: PMC6373960 DOI: 10.1371/journal.pone.0211877
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Literature search strategy.
| Database | Search Strategy |
|---|---|
| PubMed | "cervical manipulation" OR “cervical manipulations” OR "cervical mobilization" OR “cervical mobilizations” OR “cervical mobilisation" OR "thoracic manipulation" OR "thoracic manipulations" OR "thoracic mobilization" OR "manual therapy" [tw] OR "manual therapies" OR "spinal mobilization" OR "spinal mobilizations" OR "spinal mobilisation" OR "spinal manipulation" OR "spinal manipulations" OR "spine manipulation" OR "spine manipulations" OR "spine mobilization" OR "spine mobilisation" OR "manipulative therapy" OR "manipulative therapies" OR "thrust manipulation" OR “thrust manipulations” OR "orthopedic manipulation" OR “orthopedic manipulations” OR "mobilisation therapy" OR "mobilization therapy" OR “mobilization therapies” OR "manipulation therapy" OR “manipulation therapies” OR "joint mobilization" OR “joint manipulation” OR “joint manipulations” OR “joint mobilizations” OR “joint mobilisation” OR “joint mobilisations” OR spinal manipulation [mh] OR orthopedic manipulation [mh] OR manipulation [ti] OR manipulations [ti] OR mobilization [ti] OR mobilizations [ti] OR mobilisation [ti] OR mobilisations [ti] AND “neck pain” OR “cervical spine pain” OR neck pain [mh] AND (randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR placebo[tiab] OR drug therapy[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab] NOT (animals [mh] NOT humans [mh])) |
| EMBASE | 'spine manipulation'/de OR 'joint mobilization'/de OR 'orthopedic manipulation'/de OR 'manual therapy':ab,ti OR ‘manual therapies’:ab,ti OR 'manipulation therapy’ OR ‘manipulation therapies’ OR ‘mobilisation therapy’ OR ‘mobilisation therapies’ OR ‘mobilization therapy’ OR ‘mobilization therapies’ OR ‘manipulative therapy’:ab,ti OR ‘manipulative therapies’ OR (joint OR spinal OR spine OR thoracic OR cervical OR orthopedic OR orthopaedic OR thrust) NEAR/4(manipulation* OR mobilization* OR mobilisation* OR manipulative) AND 'neck pain'/de OR 'neck pain' OR 'cervical spine pain' AND 'crossover procedure':de OR 'double-blind procedure':de OR 'randomized controlled trial':de OR 'single-blind procedure':de OR (random* OR factorial* OR crossover* OR cross NEXT/1 over* OR placebo* OR doubl* NEAR/1 blind* OR singl* NEAR/1 blind* OR assign* OR allocat* OR volunteer*):de,ab,ti |
| CINAHL (EBSCO) | Joint OR spinal OR spine OR thoracic OR cervical OR orthopedic OR orthopaedic OR thrust) N4 (manipulation* OR mobilization* OR mobilisation* OR manipulative) OR "manual therapy" OR "manual therapies" OR "manipulative therapy" OR "manipulative therapies" OR “manipulation therapy” OR “manipulation therapies” OR “mobilization therapy” OR “mobilization therapies” OR “mobilisation therapy” OR “mobilisation therapies” OR MH joint mobilization OR MH manipulation, orthopedic OR MH manual therapy AND MH neck pain OR "neck pain" OR "cervical spine pain" AND random* OR PT randomized controlled trial OR PT clinical trial OR MH clinical trials+ OR AB groups OR OR placebo* OR doubl* N1 blind* OR singl* N1 blind* OR assign* OR AB allocat* OR volunteer* |
| Cochrane Central Register of Controlled Trials (EBSCO) | (Joint OR spinal OR spine OR thoracic OR cervical OR orthopedic OR orthopaedic OR thrust) N4 (manipulation* OR mobilization* OR mobilisation* OR manipulative) OR "manual therapy" OR "manual therapies" OR “manipulation therapies” OR “manipulation therapy” OR "manipulative therapy" OR "manipulative therapies" OR “mobilization therapy” OR “mobilization therapies” OR “mobilisation therapy” OR “mobilisation therapies” OR MH manipulation, spinal OR MH manipulation, orthopedic AND MH neck pain OR “neck pain” OR “cervical spine pain” |
| Pedro | “neck pain” manipulation*, “neck pain mobilisation*, “neck pain” mobilization*, “neck pain” “manual therapy”, “neck pain” “manual therapies”, “neck pain” “manipulative therapy”, “neck pain” “manipulative therapies” |
| AMED (OVID) | (mechanical neck pain OR neck pain) AND (thoracic manipulation OR thoracic thrust manipulation), mechanical neck pain AND thoracic manipulation, neck pain AND thoracic manipulation, neck pain AND manual therapy, neck pain AND manipulation |
| Clinicaltrials.gov | Conditioned searched: mechanical neck pain |
Risk of bias criteria outline by the Cochrane Collaboration.
| Study | Random Sequence Generation | Allocation Concealment | Blinding of Participants | Blinding of Providers | Blinding of Outcome Assessors | Incomplete Outcome Data–Drop Outs | Incomplete Outcome Data–ITT Analysis | Selective Reporting | Group Similarity at Baseline | Influence of Co-interventions | Compliance with Interventions | Timing of Outcomes Assessments | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cleland et al 2005 [ | + | + | + | - | + | + | + | + | + | + | + | + | 11/12 |
| Cleland et al 2007 [ | + | + | - | - | + | + | + | + | + | + | + | + | 10/12 |
| Cleland et al 2010 [ | + | + | - | - | + | + | + | + | ? | + | + | + | 9/12 |
| Gonzalez-Iglesias et al 2009 [ | + | + | + | - | + | + | + | + | + | + | + | + | 11/12 |
| Gonzalez-Iglesias et al 2009 [ | + | + | + | - | + | + | + | + | + | + | + | + | 11/12 |
| Khoja et al 2015 [ | + | + | - | - | + | - | - | + | + | - | + | + | 7/12 |
| Lau et al 2011 [ | + | + | - | - | + | + | + | + | + | + | - | + | 9/12 |
| Lee et al 2016 [ | + | + | - | - | + | + | - | + | + | - | ? | + | 7/12 |
| Martinez-Segura et al 2012 [ | + | + | - | - | + | + | + | + | + | + | + | + | 10/12 |
| Masaracchio et al 2013 [ | + | + | - | - | + | + | + | + | + | + | + | + | 10/12 |
| Puentedura et al 2011 [ | + | + | - | - | + | + | + | + | + | + | + | + | 10/12 |
| Salom-Moreno et al 2014 [ | + | + | - | - | + | + | + | + | + | + | + | + | 10/12 |
| Sillevis et al 2010 [ | + | + | + | - | + | + | + | + | + | + | + | + | 11/12 |
| Suvarnnato et al 2013 [ | + | + | - | - | + | + | + | + | + | + | + | + | 10/12 |
The risk of bias criteria outlined by the Cochrane Collaboration were used and results were labeled as + = criteria fulfilled;— = criteria not fulfilled; ? = unclear [35].
Description of studies.
| Study | Participant Characteristics | TSM Group | Comparison Group | Follow-up Time Points | Outcome Measures | Summary of Results |
|---|---|---|---|---|---|---|
| Cleland et al 2005 [ | n = 36 | Immediately following intervention | VAS | TSM group demonstrated significant improvement in pain compared to the placebo group | ||
| 27 F, 9 M | ||||||
| Age | ||||||
| Symptom duration | ||||||
| TSM 12.2wks ± 3.5wks | ||||||
| CnG 13.2wks ± 4.2wks | ||||||
| Cleland et al 2007 [ | n = 60 | 2–4 days following intervention | NPRS | TSM group experienced significant improvements in disability and pain compared to the thoracic mobilization group | ||
| 33 F, 27 M | ||||||
| Age: 43.3y ± 12.7y | ||||||
| Symptom duration: | ||||||
| TSM 54.9d ± 46d | ||||||
| CG 56.1d ± 27.6d | ||||||
| Cleland et al 2010 [ | n = 140 | 1 week of intervention (3rd visit) | NPRS | TSM group experienced significant improvements in disability and pain at each time point compared to the exercise-only group | ||
| 97 F, 43 M | ||||||
| Age: 39.9y ± 11.3y | ||||||
| Symptom duration: | ||||||
| TSM 62.5d ± 53.3d | ||||||
| CG 64.4d ± 61.3d | ||||||
| Gonzalez-Iglesias et al 2009 [ | n = 45 | 1 week after DC | NPRS | TSM group experienced significant improvements in disability and pain compared to the electrotherapy / thermal program group | ||
| 25 F, 20 M | ||||||
| Age: 34y ± 4y | ||||||
| Symptom duration: | ||||||
| TSM 18d ± 6d | ||||||
| CG 17d ± 5d | ||||||
| Gonzalez-Iglesias et al 2009 [ | n = 45 | 3 weeks of intervention (5th visit) | VAS | TSM group experienced significant improvement in pain at each time point compared to the electro / thermal therapy program group | ||
| 21 F, 24 M | ||||||
| Age: 34y ± 5y | ||||||
| Symptom duration: | ||||||
| TSM 19.5d ± 4.5d | ||||||
| CG 18.7d ± 3.9d | ||||||
| Khoja et al 2015 [ | n = 22 | 2 weeks of intervention | NPRS | No significant between group differences found for any outcome measure | ||
| 15 F, 7 M | ||||||
| Age: 38y ± 11y | ||||||
| Symptom duration: | ||||||
| TSM <3mo n = 7, 3-6mo n = 2, >6mo n = 2 | ||||||
| CG <3mo n = 6, 3-6mo n = 2, >6mo n = 2 | ||||||
| Lau et al 2011 [ | n = 120 | 4 weeks of intervention (8th visit) | NPRS | TSM group experienced significant improvements in pain and disability at each time point compared to the control group | ||
| 60 F, 60 M | ||||||
| Age: 43.78y ± 9.25y | ||||||
| Symptom duration: N/A | ||||||
| Lee et al 2016 [ | n = 46 | 10 weeks of intervention (30th visit) | VAS | TSM group experienced significant improvements in pain and disability after 10 weeks of treatment compared to DNF training and control groups | ||
| Sex: N/A | ||||||
| Age: N/A | ||||||
| Symptom duration: | ||||||
| TSM 20.7mo | ||||||
| CG 19.4mo | ||||||
| CnG 11.8mo | ||||||
| Martinez-Segura et al 2012 [ | n = 90 | 10 minutes following intervention | NPRS | No significant between group differences for pain | ||
| 46 F, 44 M | ||||||
| Age: 37y ± 8y | ||||||
| Symptom duration: | ||||||
| TSM 3.8y ± 1.5y | ||||||
| CG(R) 3.7y ± 1.5y | ||||||
| CG(L) 3.5y ± 1.4y | ||||||
| Masaracchio et al 2013 [ | n = 66 | 1 week following intervention | NPRS | TSM group experienced significant improvements in pain and disability compared to the mobilization + HEP only group | ||
| 50 F, 16 M | ||||||
| Age: 32.5y ± 11.4y | ||||||
| Symptom duration: | ||||||
| TSM 37.3d ± 25.3d | ||||||
| CG 34.5d ± 26.9d | ||||||
| Puentedura et al 2011 [ | n = 24 | 1 week of intervention (4th visit) | NPRS | No significant between group differences in disability at 1 week and 4-week follow-up, however, the cervical manipulation group experienced significant improvement in disability compared to the TSM group at 6-month follow-up | ||
| 16 F, 8 M | ||||||
| Age: 33.7y ± 6.4y | ||||||
| Symptom duration: | ||||||
| TSM 18.8d ± 9.3d | ||||||
| CG 11.5d ± 7.0d | ||||||
| Salom-Moreno et al 2014 [ | n = 52 | 10 minutes after intervention | NPRS | TSM group experienced significant improvement in pain compared to the thoracic mobilization group | ||
| 22 F, 30 M | ||||||
| Age: 33y ± 9y | ||||||
| Symptom duration: | ||||||
| TSM 2.2y ± 1.1y | ||||||
| CG 2.4y ± 1.3y | ||||||
| Sillevis et al 2010 [ | n = 100 | Immediately following intervention | VAS | No significant between group differences in pain scores | ||
| 77 F, 23 M | ||||||
| Age: TSM 42.7y | ||||||
| Placebo 46.84y | ||||||
| Symptom duration: | ||||||
| TSM 23.3mo | ||||||
| CG 25.3mo | ||||||
| Suvarnnato et al 2013 [ | n = 39 | Immediately following intervention | VAS | No significant between group differences in pain immediately post intervention or at 24-hour follow-up | ||
| 29 F, 10 M | ||||||
| Age: TSM 37y ±12.49y | ||||||
| Symptom duration: inclusion criteria indicates >3mo, no demographic data provided |
Abbreviations: AROM, active range of motion; CG. Comparison group; CnG, control group; DNF, deep neck flexor; DC, discharge; FPS, Faces Pain Scale; F, females; GROC, Global Rating of Change; HEP, home exercise program; HVLA, high-velocity low-amplitude; LT, lower trapezius; M, males; MT, middle trapezius; N/A, data not available; NDI, Neck Disability Index; NPQ, Northwick Park Neck Pain Questionnaire; NPRS, Numerical Pain Rating Scale; PT, physical therapist; PA, posterior to anterior; ROM, range of motion; SA, serratus anterior; STM, soft tissue mobilization; SP: spinous process; SCM, sternocleidomastoid; TSM: thoracic spine manipulation; TENS, transcutaneous electrical stimulation; US, ultrasound; UT, upper trapezius; VAS, visual analog scale.
*A maximum of two manipulations were delivered if no cavitation was heard on the first attempt.
†All values for age symptoms duration are reported as mean ± standard deviation when data is available
Results of included studies.
| Study | Outcome | TSM group | Comparison group | Between group differences | |||
|---|---|---|---|---|---|---|---|
| (95% CI) | |||||||
| Cleland et al 2005 [ | VAS | Pre | 41.6 ± 17.8 | Pre | 47.7 ± 18.4 | ||
| Post | 26.1 ± 17.2 | Post | 43.5 ± 19.5 | ||||
| Δ score | 15.5 ± 7.7 | Δ score | 4.2 ± 4.6 | Immediate^ | |||
| Cleland et al 2007 [ | NPRS | Pre | 5.3 ± 1.4 | Pre | 4.5 ± 2.1 | ||
| 2–4 d | 2.7 ± 1.4 | 2–4 d | 3.9 ± 2.2 | ||||
| Δ score | 2.6 ± 1.5 | Δ score | 0.54 ± 1.07 | 2–4 d | 2.03% (1.4, 2.7) | ||
| NDI | Pre | 33.5 ± 11.2 | Pre | 29.6 ± 12.6 | |||
| 2–4 d | 18.0 ± 10.9 | 2–4 d | 24.0 ± 13.4 | ||||
| Δ score | 15.5 ± 9.3 | Δ score | 5.5 ± 8.8 | 2–4 d | 10.03% (5.3, 4.7) | ||
| GROC | 2–4 d | 1.5 points higher in TSM group (0.48, 2.5) | |||||
| Cleland et al 2010 [ | NPRS | Pre | 4.4 ± 1.5 | Pre | 3.9 ± 1.4 | ||
| 1 wk | 2.3 ± 0.90 | 1 wk | 3.0 ± 1.4 | 1 wk | -0.70 (-1.1, -0.32) | ||
| 4 wk | 1.7 ± 0.91 | 4 wk | 1.9 ± 1.0 | 4 wk | -0.19 (-0.53, 0.16) | ||
| 6 mo | 1.4 ± 0.89 | 6 mo | 1.8 ± 1.0 | 6 mo | -0.35 (-0.75, 0.04) | ||
| Δ score | NA | Δ score | NA | ||||
| NDI | Pre | 29.5 ± 8.2 | Pre | 28.6 ± 7.2 | |||
| 1 wk | 14.8 ± 6.3 | 1 wk | 18.4 ± 8.2 | 1 wk | -3.6 (-6.0, -1.2) | ||
| 4 wk | 10.1 ± 5.6 | 4 wk | 13.5 ± 6.5 | 4 wk | -3.5 (-5.6, -1.3) | ||
| 6 mo | 7.1 ± 3.7 | 6 mo | 11.7 ± 7.2 | 6 mo | -4.6 (-7.0, -2.2) | ||
| Δ score | NA | Δ score | NA | ||||
| GROC | 1 wk | 18.5% of participants +5 or greater | 1 wk | 11.4% of participants +5 or greater | 1 wk | NS | |
| 4 wk | 51.4% of participants +5 or greater | 4 wk | 31.4% of participants +5 or greater | 4 wk | † | ||
| 6 mo | 80% of participants +5 or greater | 6 mo | 35.7% of participants +5 or greater | 6 mo | * | ||
| Gonzalez-Iglesias et al 2009 [ | NPRS | Pre | 5.6 ± 0.9 | Pre | 5.37 ± 0.6 | ||
| 1 wk | 2.3 ± 1.0 | 1 wk | 4.3 ± 0.8 | ||||
| Δ score | 32.8 ± 7.24 | Δ score | 9.4 ± 5.02 | 1 wk | 2.3 (2.0, 2.7) | ||
| NPQ | Pre | 27.8 ± 3.1 | Pre | 27.1 ± 2.7 | |||
| 1 wk | 15.2 ± 4.1 | 1 wk | 22.9 ± 2.9 | ||||
| Δ score | 12.6 ± 2.93 | Δ score | 4.1 ± 1.69 | 1 wk | 8.5 (7.2, 9.8) | ||
| Gonzalez-Iglesias et al 2009 [ | VAS | Pre | 54.7 ± 8.2 | Pre | 52.7 ± 5.5 | ||
| DC | 20.2 ± 7.8 | DC | 44.7 ± 5.5 | DC | 26.5 (22.9, 30.2) | ||
| 2 wk | 26.4 ± 11.8 | 2 wk | 41.2 ± 6.1 | 2 wk | 16.8 (11.7, 21.8) | ||
| 4 wk | 21.5 ± 10.6 | 4 wk | 42.2 ± 7.7 | ||||
| Δ score | 33.2 ± 9.06 | Δ score | 10.4 ± 8.72 | 4 wk | 22.8 (17.7, 27.8) | ||
| NPQ | Pre | 27.9 ± 3.0 | Pre | 27.0 ± 3.1 | |||
| DC | 15.2 ± 3.9 | DC | 23.1 ± 3.2 | DC | 8.8 (7.5, 10.1) | ||
| 2 wk | 14.7 ± 2.8 | 2 wk | 21.8 ± 3.3 | ||||
| Δ score | 13.2 ± 4.17 | Δ score | 5.1 ± 3.71 | 2 wk | 8.0 (5.8, 10.2) | ||
| Khoja et al 2015 [ | NPRS | Pre | 5.0 ± 1.7 | Pre | 5.7 ± 1.4 | ||
| 6 wk | 2.1 ± 2.4 | 6 wk | 2.9 ± 2.3 | ||||
| Δ score | 2.9 ± 2.09 | Δ score | 2.7 ± 2.38 | 6 wk | 0.2 (-1.7, 2.1) | ||
| NDI | Pre | 32.2 ± 9.4 | Pre | 33.0 ± 12.3 | |||
| 6 wk | 17.6 ± 15.2 | 6 wk | 21.3 ± 18.7 | ||||
| Δ score | 14.6 ± 15.18 | Δ score | 11.8 ± 22.25 | 6 wk | 2.9 (-11.5, 17.2) | ||
| GROC | 6 wk | 70% of participants moderately better (+4) | 6 wk | 50% of participants moderately better (+4) | |||
| Lau et al 2011 [ | NPRS | Pre | 5.02 ± 1.83 | Pre | 5.05 ± 1.48 | ||
| DC | 3.14 ± 1.99 | DC | 4.37 ± 1.75 | DC | (3.33, 4.05) | ||
| 3 mo | 3.29 ± 1.70 | 3 mo | 4.41 ± 2.02 | 3 mo | (3.46, 4.19) | ||
| 6 mo | 2.98 ± 1.76 | 6 mo | 4.24 ± 2.12 | 6 mo | (3.23, 3.99) | ||
| Δ score | NA | Δ score | NA | ||||
| NPQ | Pre | 39.15 ± 15.00 | Pre | 41.86 ± 11.66 | |||
| DC | 27.15 ± 16.84 | DC | 36.01 ± 13.47 | DC | (28.58, 34.52) | ||
| 3 mo | 27.84 ± 15.8 | 3 mo | 35.40 ± 14.4 | 3 mo | (28.49, 34.40) | ||
| 6 mo | 28.77 ± 16.03 | 6 mo | 34.80 ± 15.34 | 6 mo | (28.71, 34.86) | ||
| Δ score | NA | Δ score | NA | ||||
| Lee et al 2016 [ | VAS | Pre | 52 ± 6 | Pre (DNF) | 51 ± 6 | TSM greater improvement in pain at DC after 10 wk of treatment | |
| DC | 14 ± 5 | DC (DNF) | 25 ± 5 | ||||
| Δ score | 38 ± 6 | Δ score | 26 ± 6 | DC | |||
| Pre (C) | 53 ± 6 | ||||||
| DC (C) | 38 ± 4 | ||||||
| Δ score | 15 ± 5 | ||||||
| Korean NDI | Pre | 27.6 ± 4.5 | Pre (DNF) | 27.2 ± 3.4 | TSM greater improvement in disability at DC after 10 wk of treatment | ||
| DC | 6.6 ± 2.1 | DC (DNF) | 10.7 ± 1.8 | ||||
| Δ score | 21.0 ± 3.6 | Δ score | 16.5 ± 4.0 | DC | |||
| Pre (C) | 27.1 ± 3.9 | ||||||
| DC (C) | 20.4 ± 2.5 | ||||||
| Δ score | 6.7 ± 3.4 | ||||||
| Martinez-Segura et al 2012 [ | NPRS | Pre | 5.7 ± 1.2 | Pre (R) | 5.6 ± 1.7 | ||
| Post | 2.9 ± 1.6 | Post (R) | 2.9 ± 2.0 | ||||
| Δ score | 2.8 ± 1.61 | Δ score | 2.7 ± 1.51 | Immediate^ | NS | ||
| Pre (L) | 5.6 ± 1.2 | ||||||
| Post (L) | 2.8 ± 1.7 | ||||||
| Δ score | 2.8 ± 1.64 | ||||||
| Masaracchio et al 2013 [ | NPRS | Pre | 5.1 ± 1.2 | Pre | 4.9 ± 1.7 | ||
| 1 wk | 2.2 ± 0.9 | 1 wk | 3.5 ± 1.6 | ||||
| Δ score | 2.8 ± 6.61 | Δ score | 1.5 ± 6.9 | 1 wk | 1.3 (0.7, 2.0) | ||
| NDI | Pre | 28.5 ± 8.6 | Pre | 26.3 ± 8.4 | |||
| 1 wk | 12.3 ± 6.2 | 1 wk | 18.9 ± 8.4 | ||||
| Δ score | 16.2 ± 40.73 | Δ score | 7.4 ± 21.05 | 1 wk | 8.8 (5.4, 12.2) | ||
| GROC | 1 wk | 94% of participants moderately better (+4). Participants average moderately better (+4). | 1 wk | 35% of participants moderately better (+4). Participants average a little bit better (+2). | 1 wk | 2 points higher in TSM group (1, 3) | |
| Puentedura et al 2011 [ | NPRS | Pre | 3.6 ± 1.4 | Pre | 4.6 ± 2.2 | ||
| 1 wk | 2.1 ±1.6 | 1 wk | 0.1 ± 0.2 | 1 wk | |||
| 4 wk | 1.9 ± 1.0 | 4 wk | 0.1 ± 0.1 | 4 wk | |||
| 6 mo | 2.3 ± 1.1 | 6 mo | 0.1 ± 0.1 | 6 mo | |||
| Δ score | NA | Δ score | NA | ||||
| NDI | Pre | 12.6 ± 1.9 | Pre | 13.4 ± 2.9 | |||
| 1 wk | 10.9 ± 2.0 | 1 wk | 8.3 ± 3.4 | 1 wk | NS | ||
| 4 wk | 9.1 ± 3.7 | 4 wk | 4.2 ± 5.4 | 4 wk | NS | ||
| 6 mo | 9.9 ± 3.9 | 6 mo | 3.7 ± 5.7 | 6 mo | |||
| Δ score | NA | Δ score | NA | ||||
| GROC | 20% of participants quite a bit better (+5). Participants average moderately better (+4) at 1 wk and 4 wk, somewhat better (+3) at 6 mo. | 100% of participants quite a bit better (+5). Participants average a great deal better (+6) at 1 wk, a very great deal better (+7) at 4 wk and 6 mo. | Cervical manipulation group higher GROC scores at 1 wk, 4 wk, and 6 mo | ||||
| Salom-Moreno et al 2014 [ | NPRS | Pre | 6.0 ± 1.4 | Pre | 5.8 ± 1.2 | ||
| Post | 2.5 ± 1.7 | Post | 3.7 ± 1.5 | ||||
| Δ score | 3.5 ± 1.35 | Δ score | 2.1 ± 1.0 | Immediate | 1.4 (0.8, 2.1) | ||
| Sillevis et al 2010 [ | VAS | Pre | 38 | Pre | 33 | ||
| Post | 32 | Post | 28 | ||||
| Δ score | 5.3 | Δ score | 4.3 | Immediate | NS | ||
| Suvarnnato et al 2013 [ | VAS | Pre | 45.08 ± 18.87 | Pre (C) | 43.69 ± 15.60 | ||
| Post | 37.46 ± 19.57 | Post (C) | 38.00 ± 18.12 | Immediate | NS | ||
| 24 hr | 35.92 ± 19.77 | 24 hr (C) | 35.08 ± 14.41 | 24 hr | NS | ||
| Δ score | NA | Δ score | NA | ||||
| Pre (M) | 46.62 ± 16.66 | ||||||
| Post (M) | 38.08 ± 16.66 | ||||||
| 24 hr (M) | 35.15 ± 18.66 | ||||||
| Δ score | NA | ||||||
Abbreviations: Δ score, change score (within group difference); C, control group; DNF, deep neck flexor training group; DC, discharge; FPS, Faces Pain Scale; F/U, follow-up; GROC, Global Rating of Change; L, left cervical manipulation group; M, mobilization group; MNP, multimodal neck program; NDI, Neck Disability Index; NPQ, Northwick Park Neck Pain Questionnaire; NA, not applicable; NS, not significant; NPRS, Numerical Pain Rating Scale; R, right cervical manipulation group; SD, standard deviation; TS, thoracic spine; TSM, thoracic spine manipulation; TX, treatment; VAS, Visual Analog Scale.
*P < 0.05
†P < 0.01
‡P < 0.001
§Values are reported as mean ± standard deviation unless otherwise noted.
^Immediate follow-up was defined as less than one week following interventions
** The NPRS and VAS range from 0–10 points and 0–100 millimeters, respectively, where lower scores represent less pain and higher scores represent greater pain. The NDI and NPQ both range from 0% to 100%, where lower scores represent less disability and higher scores represent greater disability.
Fig 1PRISMA flow diagram of search results and studies included.
Fig 2Meta-analysis of TSM versus placebo TSM for pain at immediate follow-up.
Fig 3Meta-analysis of TSM versus mobilization for pain without a distinction between immediate and short-term follow-up.
Fig 4Meta-analysis of TSM versus standard care for pain at short-term follow-up.
Fig 5Meta-analysis of TSM versus standard care for pain at long-term follow-up.
Fig 6Meta-analysis of TSM versus cervical manipulation for pain without a distinction between immediate and short-term follow-up.
Fig 7Meta-analysis for TSM versus mobilization for disability without a distinction between immediate and short-term follow-up.
Fig 8Meta-analysis for TSM versus standard care for disability at short-term follow-up.
Fig 9Meta-analysis for TSM versus standard care for disability at long-term follow-up.
Adverse events* and un-wanted side effects reported in included studies.
| Study | Un-wanted side effects | Between group differences | |
|---|---|---|---|
| TSM group | Comparison group | ||
| Cleland et al 2005 [ | None reported | None reported | None reported |
| Cleland et al 2007 [ | n = 10 | n = 9 | Not significant |
| Aggravation of symptoms (8) | Aggravation of symptoms (2) | ||
| Muscle spasm (1) | Muscle spasm (1) | Duration of symptoms <24 | |
| Headache (1) | Neck stiffness (2) | hours. | |
| Headache (2) | |||
| Radiating symptoms (2) | |||
| Cleland et al 2010 [ | None reported | None reported | None reported |
| Gonzalez-Iglesias et al 2009 [ | None mentioned | None mentioned | None mentioned |
| Gonzalez-Iglesias et al 2009 [ | None mentioned | None mentioned | None mentioned |
| Khoja et al 2015 [ | None mentioned | None mentioned | None mentioned |
| Lau et al 2011 [ | None reported | None reported | None reported |
| Lee et al 2016 [ | None reported | None reported | None reported |
| Martinez-Segura et al 2012 [ | n = 1 | n = 1 | Not significant |
| Neck fatigue | Increased neck pain | ||
| Duration of symptoms <24 | |||
| hours. | |||
| Masaracchio et al 2013 [ | None reported | None reported | None reported |
| Puentedura et al 2011 [ | n = 8 | n = 1 | Greater SE reported in |
| Increased neck pain | Increased neck pain | TSM group than cervical | |
| Fatigue | manipulation group. | ||
| Headache | |||
| Upper back pain | Duration of symptoms <24 | ||
| hours. | |||
| Salom-Moreno et al 2014 [ | n = 1 | Duration of symptoms <12 | |
| Cervicothoracic discomfort | hours. | ||
| Sillevis et al 2010 [ | None mentioned | None mentioned | None mentioned |
| Suvarnnato et al 2013 [ | None mentioned | None mentioned | None mentioned |
Abbreviations: TSM, thoracic spine manipulation
*Adverse effects, AE, are defined as the sequelae following intervention that are medium to long term in duration, with moderate to severe symptoms, and of a nature that is serious, distressing, and unacceptable to the patient and requires further treatment [19]. None of the included studies documented any adverse effects, therefore, there is no data presented in this table.
†Un-wanted side effects, SE, are defined as the sequelae following intervention that are short term, mild in nature, non-serious, transient, and reversible [19].
‡None reported, The authors of the studies indicated that no participants reported any adverse events or un-wanted side effects.
§None mentioned, The authors of the studies did not report on adverse events or un-wanted side effects.
GRADE evidence profile.
| Outcome | Follow-up | Risk of bias | Inconsistency | Indirectness | Imprecision | Publication bias | Level of evidence |
|---|---|---|---|---|---|---|---|
| < 1 week | Not serious | Very serious | Not serious | Very serious | None | ⨁OOO | |
| < 3 months | Not serious | Very serious | Not serious | Serious | None | ⨁OOO | |
| < 3 months | Not serious | Not serious | Not serious | Serious | None | ⨁⨁⨁O | |
| ≥ 1 week to ≤ 3 months | Very seriousf | Very serious | Very serious | Very serious | None | ⨁OOO | |
| > 3 months | Serioush | Very serious | Very serious | Not serious | None | ⨁OOO | |
| ≥ 1 week to ≤ 3 months | Very seriousf | Very serious | Very serious | Very serious | None | ⨁OOO | |
| > 3 months | Serioush | Not serious | Very serious | Not serious | None | ⨁OOO | |
| ≤ 1 week | Not serious | Very serious | Not serious | Very serious | None | ⨁OOO | |
a Studies demonstrated variability in results.
b Symptom duration across studies is variable.
c Studies contained small sample sizes.
d Dosage of intervention varied across studies.
e Studies have wide confidence intervals.
f Studies demonstrated risk of bias associated with performance bias, attrition bias, and selection bias
g Interventions of standard care varied across studies, including general exercise, specific exercise, and modalities
h Studies demonstrated risk of bias associated with performance bias and selection bias
i One study utilized specific cervical manipulation